New research on two million people quantifies how genetic risks overlap across diagnoses

A sweeping new peer-reviewed study published in Genomic Psychiatry has introduced a concept that could reshape how psychiatrists and geneticists think about mental illness: genetic specificity. Led by Dr. Kenneth S. Kendler at Virginia Commonwealth University, the research team analyzed data from over two million individuals born in Sweden between 1950 and 1995, asking a … Read more

Stronger connection found between cannabis use and mental illness

An analysis of 35,000 Canadians shows that rising cannabis use and worsening mental‑health symptoms are increasingly appearing together, with the connection between the two strengthening over time. The study, led by McMaster University and published in The Canadian Journal of Psychiatry on Feb. 25, 2026, analyzed data from two large, nationally representative Statistics Canada surveys … Read more

As more Americans embrace anxiety treatment, MAHA derides medications

After a grueling year of chemotherapy, surgery, and radiation to treat breast cancer, Sadia Zapp was anxious — not the manageable hum that had long been part of her life, but something deeper, more distracting. “Every little ache, like my knee hurts,” she said, made her worry that “this is the end of the road … Read more

Crohn’s Disease: Early Diagnosis with Intestinal Ultrasound

Intestinal ultrasound (IUS) emerges as a game-changer in the early ⁣management of Crohn’s disease, offering a non-invasive method ​too predict remission. According to a⁢ recent study, IUS shows that improvements in IUS parameters within the first year correlate with enhanced patient​ outcomes, specifically with over a third of patients achieving⁣ remission within months. ⁣this innovative … Read more

New Drug for Acute Schizophrenia Effective in Phase 2 Study

LOS ANGELES — The novel phosphodiesterase 10A (PDE10A) inhibitor known as CPL’36 (Celon Pharma) is effective and generally safe in acute exacerbations of schizophrenia, new research suggested. In a phase 2 trial of 189 patients with acute schizophrenia, compared with the placebo group, the groups receiving CPL’36 20 or 40 mg once daily both met … Read more

Doctors’ Anxiety: Breaking the Silence

Archyde: Latest World News, Economy, Entertainment, Health, Technology & Sports Updates “`html Anxiety in Healthcare: Addressing teh Silent Epidemic Anxiety in Healthcare: Addressing the Silent Epidemic the relentless demands of healthcare often cast a long shadow, leading to a silent epidemic of anxiety in healthcare professionals. This isn’t just about occasional stress; it’s a pervasive … Read more

Doctors With Anxiety Disorders Say Break Silence, Get Help

Be sure to scroll down after this story to find links to extensive Medscape Medical News coverage addressing mental health and medical professionals. The nightmares started in his second quarter of medical school. Darrell Kirch, MD Darrell Kirch, MD, had struggled with anxiety since early childhood but this was another level. He was feeling burned … Read more

Ultra-processed foods increase risk of anxiety and depression, study shows

A major population study reveals that diets high in ultra-processed foods are tied to poorer mental health, and uncovers biological markers that help explain the link. Study: Associations of Ultra-Processed Food Intake and Its Circulating Metabolomic Signature with Mental Disorders in Middle-Aged and Older Adults. Image Credit: Lightspring / Shutterstock In a recent study published in the … Read more

Vitiligo Study Identifies Three Patient Burden Profiles

TOPLINE: A recent study identified three clinically distinct vitiligo profiles on the basis of Vitiligo Patient Priority Outcomes (ViPPO) responses from real-world patient data. Classes with more severe emotional and social functioning impacts had more severe disease per physician assessment, visible areas of lesion involvement, and work productivity and quality-of-life (QoL) impairment. METHODOLOGY: Researchers collected … Read more

Low sNRP-1 Levels Tied to Depression in Newly Diagnosed T2D

TOPLINE: Low levels of soluble neuropilin-1 (sNRP-1) were associated with depression in patients with newly diagnosed type 2 diabetes (T2D), with the association remaining consistent across all age groups. METHODOLOGY: The NRP-1 receptor is an essential transmembrane glycoprotein involved in the development of the nervous and cardiovascular systems, as well as immune regulation, and may … Read more